Birdwatch Note
2024-08-01 23:35:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
L'auteur présente 2 erreurs factuelles. Imane Khelif est une femme atteinte d'hyperandrogénie. Cette particularité touche 5% des femmes. Le CIO a confirmé son éligibilité aux JO et lui apporte son soutien. Les élus ne participent en rien à la désignation des athlètes aux JO https://www.ouest-france.fr/sport/boxe/jo-2024-boxe-elle-respecte-les-regles-deligibilite-le-cio-prend-la-defense-dimane-khelif-78a5892e-5043-11ef-b169-5a3a31fb9518 https://www.lefigaro.fr/sports/jeux-olympiques/jo-boxe-controverse-apres-l-abandon-de-l-adversaire-italienne-d-imane-khelif-20240801 https://www.eurosport.fr/boxe/paris-2024/2024/controverse-autour-de-boxeuses-olympiques-la-testosterone-en-question_sto20024187/story.shtml
Written by 86D38FEBF1476B91DE0257B70BD81C88B245E5A5DA65446424DC4F517F8A1A32
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819021709556560209
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819155115384680764
- noteId - 1819155115384680764
- participantId -
- noteAuthorParticipantId - 86D38FEBF1476B91DE0257B70BD81C88B245E5A5DA65446424DC4F517F8A1A32 Participant Details
- createdAtMillis - 1722555352433
- tweetId - 1819021709556560209
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- L'auteur présente 2 erreurs factuelles. Imane Khelif est une femme atteinte d'hyperandrogénie. Cette particularité touche 5% des femmes. Le CIO a confirmé son éligibilité aux JO et lui apporte son soutien. Les élus ne participent en rien à la désignation des athlètes aux JO https://www.ouest-france.fr/sport/boxe/jo-2024-boxe-elle-respecte-les-regles-deligibilite-le-cio-prend-la-defense-dimane-khelif-78a5892e-5043-11ef-b169-5a3a31fb9518 https://www.lefigaro.fr/sports/jeux-olympiques/jo-boxe-controverse-apres-l-abandon-de-l-adversaire-italienne-d-imane-khelif-20240801 https://www.eurosport.fr/boxe/paris-2024/2024/controverse-autour-de-boxeuses-olympiques-la-testosterone-en-question_sto20024187/story.shtml
Note Ratings
| rated at | rated by | |
| 2024-08-07 17:21:30 -0500 | Rating Details | |
| 2024-08-05 06:44:04 -0500 | Rating Details | |
| 2024-08-04 07:25:35 -0500 | Rating Details | |
| 2024-08-04 05:58:44 -0500 | Rating Details | |
| 2024-08-04 03:59:42 -0500 | Rating Details | |
| 2024-08-03 14:50:31 -0500 | Rating Details | |
| 2024-08-03 12:53:24 -0500 | Rating Details | |
| 2024-08-03 10:36:44 -0500 | Rating Details | |
| 2024-08-03 02:58:26 -0500 | Rating Details | |
| 2024-08-02 18:38:22 -0500 | Rating Details | |
| 2024-08-02 18:07:27 -0500 | Rating Details | |
| 2024-08-02 10:51:35 -0500 | Rating Details | |
| 2024-08-02 10:35:49 -0500 | Rating Details | |
| 2024-08-02 08:10:18 -0500 | Rating Details | |
| 2024-08-02 07:44:46 -0500 | Rating Details | |
| 2024-08-02 07:36:55 -0500 | Rating Details | |
| 2024-08-02 07:03:50 -0500 | Rating Details | |
| 2024-08-02 06:41:47 -0500 | Rating Details | |
| 2024-08-02 06:30:23 -0500 | Rating Details | |
| 2024-08-02 05:59:05 -0500 | Rating Details | |
| 2024-08-02 05:35:46 -0500 | Rating Details | |
| 2024-08-02 04:50:40 -0500 | Rating Details | |
| 2024-08-02 02:59:23 -0500 | Rating Details | |
| 2024-08-02 02:57:01 -0500 | Rating Details | |
| 2024-08-02 02:53:33 -0500 | Rating Details | |
| 2024-08-02 02:39:14 -0500 | Rating Details | |
| 2024-08-02 02:35:14 -0500 | Rating Details | |
| 2024-08-02 02:10:43 -0500 | Rating Details | |
| 2024-08-02 02:03:52 -0500 | Rating Details | |
| 2024-08-02 01:57:30 -0500 | Rating Details | |
| 2024-08-02 01:55:13 -0500 | Rating Details | |
| 2024-08-02 01:53:43 -0500 | Rating Details | |
| 2024-08-02 01:47:04 -0500 | Rating Details | |
| 2024-08-02 01:25:45 -0500 | Rating Details | |
| 2024-08-02 01:14:26 -0500 | Rating Details | |
| 2024-08-02 01:12:07 -0500 | Rating Details | |
| 2024-08-02 00:59:03 -0500 | Rating Details | |
| 2024-08-02 00:58:54 -0500 | Rating Details | |
| 2024-08-02 00:46:42 -0500 | Rating Details | |
| 2024-08-02 00:46:37 -0500 | Rating Details | |
| 2024-08-02 00:44:00 -0500 | Rating Details | |
| 2024-08-02 00:38:09 -0500 | Rating Details | |
| 2024-08-02 00:31:36 -0500 | Rating Details | |
| 2024-08-02 00:27:34 -0500 | Rating Details | |
| 2024-08-02 00:20:20 -0500 | Rating Details | |
| 2024-08-02 00:13:18 -0500 | Rating Details | |
| 2024-08-02 00:04:37 -0500 | Rating Details | |
| 2024-08-01 23:57:12 -0500 | Rating Details | |
| 2024-08-01 23:54:35 -0500 | Rating Details | |
| 2024-08-01 23:50:16 -0500 | Rating Details | |
| 2024-08-01 23:33:54 -0500 | Rating Details | |
| 2024-08-01 23:09:31 -0500 | Rating Details | |
| 2024-08-01 21:27:04 -0500 | Rating Details | |
| 2024-08-01 21:13:07 -0500 | Rating Details | |
| 2024-08-01 20:59:59 -0500 | Rating Details | |
| 2024-08-01 20:58:05 -0500 | Rating Details | |
| 2024-08-01 20:23:40 -0500 | Rating Details | |
| 2024-08-01 20:20:26 -0500 | Rating Details | |
| 2024-08-01 20:05:57 -0500 | Rating Details | |
| 2024-08-01 20:02:16 -0500 | Rating Details | |
| 2024-08-01 20:02:15 -0500 | Rating Details | |
| 2024-08-01 19:59:20 -0500 | Rating Details | |
| 2024-08-01 19:56:55 -0500 | Rating Details | |
| 2024-08-01 19:55:02 -0500 | Rating Details | |
| 2024-08-01 19:50:55 -0500 | Rating Details | |
| 2024-08-01 19:35:05 -0500 | Rating Details | |
| 2024-08-01 19:33:35 -0500 | Rating Details | |
| 2024-08-01 19:25:46 -0500 | Rating Details | |
| 2024-08-01 19:16:29 -0500 | Rating Details | |
| 2024-08-01 19:03:18 -0500 | Rating Details | |
| 2024-08-01 18:59:16 -0500 | Rating Details | |
| 2024-08-01 18:57:32 -0500 | Rating Details | |
| 2024-08-01 18:56:36 -0500 | Rating Details | |
| 2024-08-01 18:51:53 -0500 | Rating Details | |
| 2024-08-01 18:40:07 -0500 | Rating Details | |
| 2024-08-05 05:17:54 -0500 | Rating Details | |
| 2024-08-04 04:37:06 -0500 | Rating Details | |
| 2024-08-02 11:08:46 -0500 | Rating Details | |
| 2024-08-02 10:32:51 -0500 | Rating Details | |
| 2024-08-02 09:00:07 -0500 | Rating Details | |
| 2024-08-02 07:56:16 -0500 | Rating Details | |
| 2024-08-02 05:20:20 -0500 | Rating Details | |
| 2024-08-02 04:59:49 -0500 | Rating Details | |
| 2024-08-02 04:47:22 -0500 | Rating Details | |
| 2024-08-02 03:35:41 -0500 | Rating Details | |
| 2024-08-02 03:21:13 -0500 | Rating Details | |
| 2024-08-02 02:56:23 -0500 | Rating Details | |
| 2024-08-02 02:13:17 -0500 | Rating Details | |
| 2024-08-02 01:33:11 -0500 | Rating Details | |
| 2024-08-02 00:52:52 -0500 | Rating Details | |
| 2024-08-02 00:23:52 -0500 | Rating Details | |
| 2024-08-01 23:48:47 -0500 | Rating Details | |
| 2024-08-01 23:45:07 -0500 | Rating Details | |
| 2024-08-01 23:23:44 -0500 | Rating Details | |
| 2024-08-01 23:15:17 -0500 | Rating Details | |
| 2024-08-01 21:51:00 -0500 | Rating Details | |
| 2024-08-01 20:30:17 -0500 | Rating Details | |
| 2024-08-01 20:25:41 -0500 | Rating Details | |
| 2024-08-01 19:43:49 -0500 | Rating Details | |
| 2024-08-01 19:32:05 -0500 | Rating Details | |
| 2024-08-01 19:23:34 -0500 | Rating Details | |
| 2024-08-01 19:22:56 -0500 | Rating Details | |
| 2024-08-01 19:21:37 -0500 | Rating Details | |
| 2024-08-01 19:08:30 -0500 | Rating Details | |
| 2024-08-09 07:32:11 -0500 | Rating Details | |
| 2024-08-30 07:10:19 -0500 | Rating Details |